Advice
in the absence of a submission from the holder of the marketing authorisation
voriconazole (Vfend) is not recommended for use within NHS Scotland.
Indication under review: Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice110KB (PDF)
Medicine details
- Medicine name:
- voriconazole (Vfend)
- SMC ID:
- 1014/14
- Indication:
- Prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (HSCT) recipients.
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Infections
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 10 November 2014